Passa al contenuto
Merck

[The combined therapy with valdoxan and amitriptyline of treatment resistant somatized depression].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2013-03-27)
V S Sobennikov, M L Prokop'eva
ABSTRACT

The combined treatment with valdoxan and amitriptyline has been suggested as one of the possible variants to overcome treatment resistance in somatized depression. A study design was based on the rhythmological model of depression which clinically characterized by altered sleep-awakeness cycles. According to this notion, 36 patients were divided into two groups by the presence (20 patients) or absence (16 patients) of severe sleep disorders. The combined treatment was more effective in the first group of patients with insomnia which was an indicator of altered sleep-awakeness cycles.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Amitriptyline hydrochloride, ≥98% (TLC), powder
Supelco
Amitriptyline hydrochloride solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Agomelatine, ≥98% (HPLC)